Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | Is haploidentical the best curative option for sickle cell disease?

Miguel Abbout, MD, American University of Beirut, Beirut, Lebanon, evaluates whether haploidentical stem cell transplantation is the best curative option for sickle cell disease at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.